| Code | CSB-MP7005MOV |
| Abbreviation | Recombinant Cynomolgus monkey TNFRSF1A protein, partial (Active) |
| MSDS | |
| Size | $190 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
TNFR1 mediates the pleiotropic effects of TNF-α in inflammation, apoptosis, and immune regulation, making it a critical target in cancer immunology and therapeutic antibody development. This recombinant cynomolgus monkey TNFRSF1A, spanning the extracellular ligand-binding domain (residues 30–211), demonstrates quantifiable binding to human TNF with an EC50 of 10.33–12.16 ng/mL in functional ELISA, confirming that mammalian expression preserves the native conformational epitopes required for high-affinity ligand recognition. The validated activity supports use in ligand-binding assays, competitive inhibition screens for TNF-blocking biologics, and therapeutic antibody epitope mapping where cross-reactivity between human and cynomolgus orthologs must be characterized for preclinical safety studies. With purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, this protein meets the quality thresholds commonly required for SPR affinity characterization, biolayer interferometry kinetics, and antibody screening workflows in oncology drug discovery.
There are currently no reviews for this product.